(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-1.36%) $82.71
(6.71%) $2.05
(0.05%) $2 348.30
(-0.35%) $27.44
(4.08%) $959.75
(-0.23%) $0.933
(0.09%) $11.03
(-0.55%) $0.796
(1.55%) $93.30
0.00% HKD 0.560
Live Chart Being Loaded With Signals
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China...
Stats | |
---|---|
Volumen de hoy | 16.35M |
Volumen promedio | 7.60M |
Capitalización de mercado | 5.20B |
EPS | HKD0 ( 2024-03-27 ) |
Last Dividend | HKD0.0370 ( 2023-06-06 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -56.00 |
ATR14 | HKD0.00100 (0.18%) |
Volumen Correlación
Sihuan Pharmaceutical Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Sihuan Pharmaceutical Correlación - Moneda/Commodity
Sihuan Pharmaceutical Finanzas
Annual | 2023 |
Ingresos: | HKD1.86B |
Beneficio Bruto: | HKD1.30B (69.64 %) |
EPS: | HKD-0.00580 |
FY | 2023 |
Ingresos: | HKD1.86B |
Beneficio Bruto: | HKD1.30B (69.64 %) |
EPS: | HKD-0.00580 |
FY | 2022 |
Ingresos: | HKD2.18B |
Beneficio Bruto: | HKD1.49B (68.20 %) |
EPS: | HKD-0.210 |
FY | 2021 |
Ingresos: | HKD3.29B |
Beneficio Bruto: | HKD2.45B (74.39 %) |
EPS: | HKD0.0440 |
Financial Reports:
No articles found.
Sihuan Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.0360 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.0370 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0390 | 2011-09-21 |
Last Dividend | HKD0.0370 | 2023-06-06 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 23 | -- |
Total Paid Out | HKD0.764 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.03 | -- |
Div. Sustainability Score | 3.27 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.991 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6117.HK | Ex Dividend Junior | 2023-05-22 | Sporadic | 0 | 0.00% | |
1857.HK | Ex Dividend Junior | 2023-08-23 | Semi-Annually | 0 | 0.00% | |
0881.HK | Ex Dividend Junior | 2023-06-23 | Annually | 0 | 0.00% | |
0026.HK | Ex Dividend Junior | 2023-10-03 | Semi-Annually | 0 | 0.00% | |
2669.HK | Ex Dividend Knight | 2023-06-23 | Semi-Annually | 0 | 0.00% | |
1428.HK | Ex Dividend Knight | 2023-08-23 | Annually | 0 | 0.00% | |
0518.HK | Ex Dividend Junior | 2023-09-01 | Sporadic | 0 | 0.00% | |
6869.HK | Ex Dividend Junior | 2023-07-04 | Annually | 0 | 0.00% | |
1977.HK | Ex Dividend Knight | 2023-09-11 | Semi-Annually | 0 | 0.00% | |
1036.HK | Ex Dividend Junior | 2023-06-21 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0290 | 1.500 | -0.581 | -0.871 | [0 - 0.5] |
returnOnAssetsTTM | -0.00468 | 1.200 | -0.156 | -0.187 | [0 - 0.3] |
returnOnEquityTTM | -0.0122 | 1.500 | -1.247 | -1.870 | [0.1 - 1] |
payoutRatioTTM | -5.53 | -1.000 | -10.00 | 10.00 | [0 - 1] |
currentRatioTTM | 1.511 | 0.800 | 7.45 | 5.96 | [1 - 3] |
quickRatioTTM | 1.160 | 0.800 | 7.88 | 6.30 | [0.8 - 2.5] |
cashRatioTTM | 0.920 | 1.500 | 6.00 | 9.00 | [0.2 - 2] |
debtRatioTTM | 0.106 | -1.500 | 8.23 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.00318 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.00510 | 2.00 | -0.00255 | -0.00510 | [0 - 20] |
debtEquityRatioTTM | 0.277 | -1.500 | 8.89 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.696 | 1.000 | 1.727 | 1.727 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0736 | 1.000 | -3.47 | -3.47 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0231 | 1.000 | -0.983 | -0.983 | [0.2 - 2] |
assetTurnoverTTM | 0.161 | 0.800 | -2.26 | -1.806 | [0.5 - 2] |
Total Score | 3.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -85.44 | 1.000 | -8.73 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0122 | 2.50 | -0.802 | -1.870 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.00510 | 2.00 | -0.00170 | -0.00510 | [0 - 30] |
dividendYielPercentageTTM | 7.14 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.00318 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | -5.53 | 1.500 | -10.00 | 10.00 | [0 - 1] |
pegRatioTTM | -0.934 | 1.500 | -9.56 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0152 | 1.000 | -2.12 | 0 | [0.1 - 0.5] |
Total Score | -1.286 |
Sihuan Pharmaceutical
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico